UMEXPERT - DR. CHAN WAH LOONG

ARTICLE IN ACADEMIC JOURNALS

NO	DETAILS OF ARTICLE IN ACADEMIC JOURNALS
1.	LIVERSTAT for risk stratification for patients with metabolic dysfunction-associated fatty liver disease 2024 Author(s) : Sanjiv A/l K. Mahadeva, Chan Wah Kheong, Lai Lee Lee, Chan Wah Loong Source : JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY DOI : 10.1111/jgh.16675
2.	Editorial: The Impact of Socioeconomic and Ethnic Factors on Chronic Liver Disease 2024 Author(s) : Chuah Kee Huat, Chan Wah Loong Source : ALIMENTARY PHARMACOLOGY & THERAPEUTICS DOI : 10.1111/apt.18304
3.	Fibroscan-AST (FAST) score and other non-invasive tests for the diagnosis of fibrotic non-alcoholic steatohepatitis 2023 Author(s) : Chan Wah Kheong, Chan Wah Loong Source : HEPATOBILIARY SURGERY AND NUTRITION DOI : 10.21037/hbsn-23-346
4.	The use of non-invasive tests compared with histological fibrosis stage in predicting liver-related events in metabolic dysfunction-associated fatty liver disease 2023 Author(s) : Sanjiv A/l K. Mahadeva, Chan Wah Kheong, Chuah Kee Huat, Chan Wah Loong Source : JOURNAL OF HEPATOLOGY
5.	Long-term clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease: a single-centre prospective cohort study with baseline liver biopsy 2023 Author(s) : Sanjiv A/l K. Mahadeva, Chan Wah Kheong, Lai Lee Lee, Chuah Kee Huat, Chan Wah Loong Source : HEPATOLOGY INTERNATIONAL DOI : 10.1007/s12072-023-10550-9